Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (PATHWAY)

This study has been terminated.
(Commercial decision to discontinue the study)
Sponsor:
Information provided by:
Progen Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00568308
First received: December 4, 2007
Last updated: June 13, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)